The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 7, 2026 | Bender Jeremy | Director | Grant(A) | 60K | — | $0 |
| Jul 7, 2026 | Bender Jeremy | Director | Grant(A) | 30K | — | $0 |
| Jul 1, 2026 | Kilroy Conor | See Remarks | Grant(A) | 15K | — | $0 |
| Jun 16, 2026 | Gibney Anthony S | See Remarks | Sell(S) | 13K | $6.42 | $82K |
| Jun 11, 2026 | Bitetti Teresa Marie | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2026 | Bitetti Teresa Marie | Director | Grant(A) | 15K | — | $0 |
| Jun 11, 2026 | Srivastava Sapna | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2026 | Srivastava Sapna | Director | Grant(A) | 15K | — | $0 |
| Jun 11, 2026 | Johnson David Michael | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2026 | Johnson David Michael | Director | Grant(A) | 15K | — | $0 |
| Jun 11, 2026 | Mattessich Antony C. | Director | Grant(A) | 30K | — | $0 |
| Jun 11, 2026 | Mattessich Antony C. | Director | Grant(A) | 15K | — | $0 |
| May 19, 2026 | Holles Natalie C. | See Remarks, Director | Grant(A) | 2.2M | — | $0 |
| May 19, 2026 | Holles Natalie C. | See Remarks, Director | Grant(A) | 554K | — | $0 |
| May 19, 2026 | Holles Natalie C. | See Remarks, Director | Grant(A) | 600K | — | $0 |
| May 7, 2026 | Matrix Capital Management Company, LP | 10% Owner | Sell(S) | 6.9M | $5.64 | $39.0M |
| Apr 16, 2026 | Kilroy Conor | See Remarks | Sell(S) | 12K | $7.02 | $82K |
| Mar 2, 2026 | Elazzouzi Amy | Senior Vice President, Finance | Grant(A) | 45K | — | $0 |
| Mar 2, 2026 | Elazzouzi Amy | Senior Vice President, Finance | Grant(A) | 80K | — | $0 |
| Mar 2, 2026 | Hopkins Janet Jill | Chief Medical Officer | Grant(A) | 89K | — | $0 |
| Mar 2, 2026 | Hopkins Janet Jill | Chief Medical Officer | Grant(A) | 161K | — | $0 |
| Mar 2, 2026 | Plavsic Mark | Chief Technology Officer | Grant(A) | 62K | — | $0 |
| Mar 2, 2026 | Plavsic Mark | Chief Technology Officer | Grant(A) | 113K | — | $0 |
| Mar 2, 2026 | de los Pinos Elisabet | See Remarks, Director | Grant(A) | 166K | — | $0 |
| Mar 2, 2026 | de los Pinos Elisabet | See Remarks, Director | Grant(A) | 249K | — | $0 |
| Mar 2, 2026 | Gibney Anthony S | See Remarks | Grant(A) | 71K | — | $0 |
| Mar 2, 2026 | Gibney Anthony S | See Remarks | Grant(A) | 129K | — | $0 |
| Mar 2, 2026 | Kilroy Conor | See Remarks | Grant(A) | 62K | — | $0 |
| Mar 2, 2026 | Kilroy Conor | See Remarks | Grant(A) | 113K | — | $0 |
| Feb 17, 2026 | de los Pinos Elisabet | See Remarks, Director | Sell(S) | 48K | $5.06 | $241K |
| Feb 17, 2026 | Elazzouzi Amy | Senior Vice President, Finance | Sell(S) | 9K | $5.06 | $43K |
| Feb 17, 2026 | Hopkins Janet Jill | Chief Medical Officer | Sell(S) | 20K | $5.06 | $103K |
| Feb 17, 2026 | Plavsic Mark | Chief Technology Officer | Sell(S) | 16K | $5.05 | $80K |
| Feb 17, 2026 | Kilroy Conor | See Remarks | Sell(S) | 12K | $5.05 | $61K |
| Jan 20, 2026 | de los Pinos Elisabet | See Remarks, Director | Sell(S) | 17K | $4.86 | $82K |
| Jan 20, 2026 | Elazzouzi Amy | Senior Vice President, Finance | Sell(S) | 2K | $4.86 | $8K |
| Nov 17, 2025 | Hopkins Janet Jill | Chief Medical Officer | Sell(S) | 17K | $5.42 | $93K |
| Oct 29, 2025 | de los Pinos Elisabet | See Remarks, Director | Sell(S) | 9K | $6.35 | $57K |
| Oct 29, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Sell(S) | 896 | $6.35 | $6K |
| Oct 16, 2025 | Plavsic Mark | Chief Technology Officer | Sell(S) | 12K | $6.35 | $77K |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 2K | $4.25 | $10K |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 1K | $5.48 | $6K |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 547 | $5.21 | $3K |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 547 | $5.48 | $3K |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 5K | $2.74 | $13K |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Sell(S) | 8K | $6.70 | $52K |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 3K | $5.07 | $13K |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 1K | $3.16 | $3K |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 1K | — | $0 |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 547 | — | $0 |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 5K | — | $0 |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 1K | — | $0 |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 2K | — | $0 |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 3K | — | $0 |
| Aug 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Option exercise(M) | 547 | — | $0 |
| Jun 17, 2025 | Mattessich Antony C. | Director | Grant(A) | 13K | — | $0 |
| Jun 17, 2025 | Mattessich Antony C. | Director | Grant(A) | 17K | — | $0 |
| Jun 17, 2025 | Johnson David Michael | Director | Grant(A) | 13K | — | $0 |
| Jun 17, 2025 | Johnson David Michael | Director | Grant(A) | 17K | — | $0 |
| Jun 17, 2025 | Srivastava Sapna | Director | Grant(A) | 13K | — | $0 |
| Jun 17, 2025 | Srivastava Sapna | Director | Grant(A) | 17K | — | $0 |
| Jun 2, 2025 | de los Pinos Elisabet | See Remarks, Director | Option exercise(M) | 11K | $5.07 | $56K |
| Jun 2, 2025 | de los Pinos Elisabet | See Remarks, Director | Tax withholding(F) | 10K | $6.16 | $61K |
| Jun 2, 2025 | de los Pinos Elisabet | See Remarks, Director | Option exercise(M) | 11K | — | $0 |
| Jun 2, 2025 | Gibney Anthony S | See Remarks | Grant(A) | 150K | — | $0 |
| Jun 2, 2025 | Gibney Anthony S | See Remarks | Grant(A) | 250K | — | $0 |
| May 16, 2025 | Gibney Anthony S | See Remarks | Buy(P) | 50K | $4.90 | $245K |
| May 16, 2025 | Gibney Anthony S | See Remarks | Sell(S) | 2K | $5.15 | $8K |
| May 16, 2025 | Gibney Anthony S | See Remarks | Buy(P) | 13K | — | — |
| May 16, 2025 | Johnson David Michael | Director | Buy(P) | 20K | $4.90 | $98K |
| May 16, 2025 | Johnson David Michael | Director | Buy(P) | 5K | — | — |
| Apr 16, 2025 | Kilroy Conor | See Remarks | Sell(S) | 7K | $5.49 | $39K |
| Apr 16, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Sell(S) | 897 | $5.49 | $5K |
| Mar 31, 2025 | Bitetti Teresa Marie | Director | Grant(A) | 21K | — | $0 |
| Mar 31, 2025 | Bitetti Teresa Marie | Director | Grant(A) | 29K | — | $0 |
| Feb 18, 2025 | de los Pinos Elisabet | See Remarks, Director | Sell(S) | 20K | $7.75 | $157K |
| Feb 18, 2025 | Hopkins Janet Jill | Chief Medical Officer | Sell(S) | 3K | $7.75 | $20K |
| Feb 18, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Sell(S) | 1K | $7.75 | $11K |
| Feb 18, 2025 | Plavsic Mark | Chief Technology Officer | Sell(S) | 2K | $7.75 | $17K |
| Feb 3, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Grant(A) | 45K | — | $0 |
| Feb 3, 2025 | Elazzouzi Amy | Senior Vice President, Finance | Grant(A) | 30K | — | $0 |
| Feb 3, 2025 | Kilroy Conor | See Remarks | Grant(A) | 90K | — | $0 |
| Feb 3, 2025 | Kilroy Conor | See Remarks | Grant(A) | 60K | — | $0 |
| Feb 3, 2025 | Hopkins Janet Jill | Chief Medical Officer | Grant(A) | 121K | — | $0 |
| Feb 3, 2025 | Hopkins Janet Jill | Chief Medical Officer | Grant(A) | 79K | — | $0 |
| Feb 3, 2025 | Plavsic Mark | Chief Technology Officer | Grant(A) | 90K | — | $0 |
| Feb 3, 2025 | Plavsic Mark | Chief Technology Officer | Grant(A) | 60K | — | $0 |
| Feb 3, 2025 | de los Pinos Elisabet | See Remarks, Director | Grant(A) | 194K | — | $0 |
| Feb 3, 2025 | de los Pinos Elisabet | See Remarks, Director | Grant(A) | 256K | — | $0 |
| Jan 21, 2025 | Elazzouzi Amy | Vice President, Finance | Sell(S) | 1K | $7.67 | $8K |
| Jan 21, 2025 | de los Pinos Elisabet | See Remarks, Director | Sell(S) | 16K | $7.67 | $122K |
| Nov 18, 2024 | Hopkins Janet Jill | Chief Medical Officer | Sell(S) | 12K | $9.36 | $111K |
| Oct 29, 2024 | Elazzouzi Amy | Vice President, Finance | Sell(S) | 553 | $10.74 | $6K |
| Oct 29, 2024 | de los Pinos Elisabet | See Remarks, Director | Sell(S) | 9K | $10.74 | $99K |
| Oct 18, 2024 | de los Pinos Elisabet | See Remarks, Director | Option exercise(M) | 25K | $2.74 | $68K |
| Oct 18, 2024 | de los Pinos Elisabet | See Remarks, Director | Sell(S) | 25K | $12.04 | $301K |
| Oct 18, 2024 | de los Pinos Elisabet | See Remarks, Director | Option exercise(M) | 25K | — | $0 |
| Oct 18, 2024 | Feder Julie B | Chief Financial Officer | Sell(S) | 25K | $12.03 | $302K |
| Oct 18, 2024 | Feder Julie B | Chief Financial Officer | Option exercise(M) | 18K | $2.74 | $48K |
| Oct 18, 2024 | Feder Julie B | Chief Financial Officer | Option exercise(M) | 3K | $4.25 | $11K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).